Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Investview (INVU) Revenue (2016 - 2025)

Historic Revenue for Investview (INVU) over the last 16 years, with Q3 2025 value amounting to $9.1 million.

  • Investview's Revenue fell 2290.98% to $9.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $41.0 million, marking a year-over-year decrease of 2990.88%. This contributed to the annual value of $52.4 million for FY2024, which is 2287.79% down from last year.
  • Latest data reveals that Investview reported Revenue of $9.1 million as of Q3 2025, which was down 2290.98% from $10.0 million recorded in Q2 2025.
  • In the past 5 years, Investview's Revenue registered a high of $25.6 million during Q2 2021, and its lowest value of $9.1 million during Q3 2025.
  • Over the past 5 years, Investview's median Revenue value was $14.9 million (recorded in 2022), while the average stood at $15.4 million.
  • Per our database at Business Quant, Investview's Revenue soared by 35845.1% in 2021 and then crashed by 4238.16% in 2022.
  • Over the past 5 years, Investview's Revenue (Quarter) stood at $23.4 million in 2021, then crashed by 38.65% to $14.3 million in 2022, then rose by 25.02% to $17.9 million in 2023, then tumbled by 33.84% to $11.9 million in 2024, then decreased by 23.67% to $9.1 million in 2025.
  • Its Revenue was $9.1 million in Q3 2025, compared to $10.0 million in Q2 2025 and $10.0 million in Q1 2025.